Stryker price target raised to $265, added to ‘TAP Outperform’ list at Evercore

Evercore ISI analyst Vijay Kumar raised the firm’s price target on Stryker to $265 from $240 and keeps an Outperform rating on the shares, which he is adding to the firm’s "TAP Outperform" list ahead of its Q4 report.